A citation-based method for searching scientific literature

F John Service. Diabetes 2013
Times Cited: 117







List of co-cited articles
447 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
194
4

Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes.
Matthew Riddle, Guillermo Umpierrez, Andres DiGenio, Rong Zhou, Julio Rosenstock. Diabetes Care 2011
153
3

Diabetes: Models, Signals, and Control.
Claudio Cobelli, Chiara Dalla Man, Giovanni Sparacino, Lalo Magni, Giuseppe De Nicolao, Boris P Kovatchev. IEEE Rev Biomed Eng 2009
154
3

Reference values for continuous glucose monitoring in Chinese subjects.
Jian Zhou, Hong Li, Xingwu Ran, Wenying Yang, Qiang Li, Yongde Peng, Yanbing Li, Xin Gao, Xiaojun Luan, Weiqing Wang,[...]. Diabetes Care 2009
84
3

The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed.
Peter A Baghurst, David Rodbard, Fergus J Cameron. J Diabetes Sci Technol 2010
28
10

Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes.
Klaus-Dieter Kohnert, Petra Augstein, Peter Heinke, Eckhard Zander, Karolina Peterson, Ernst-Joachim Freyse, Eckhard Salzsieder. Diabetes Res Clin Pract 2007
44
6

Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
Shu-Hua Mi, Gong Su, Zhao Li, Hong-Xia Yang, Hong Zheng, Hong Tao, Yun Zhou, Lei Tian. Chin Med J (Engl) 2012
12
25

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
Itamar Raz, Peter W F Wilson, Krzysztof Strojek, Irina Kowalska, Velimir Bozikov, Anselm K Gitt, György Jermendy, Barbara N Campaigne, Lisa Kerr, Zvonko Milicevic,[...]. Diabetes Care 2009
229
3

Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.
Maria Rosaria Rizzo, Raffaele Marfella, Michelangela Barbieri, Virginia Boccardi, Francesco Vestini, Biagio Lettieri, Silvestro Canonico, Giuseppe Paolisso. Diabetes Care 2010
123
3

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.
Louis Monnier, Claude Colette, Gareth J Dunseath, David R Owens. Diabetes Care 2007
282
3

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.
M Hanefeld, S Fischer, U Julius, J Schulze, U Schwanebeck, H Schmechel, H J Ziegelasch, J Lindner. Diabetologia 1996
700
3

Average daily risk range as a measure for clinical research and routine care.
Susana R Patton, Mark A Clements. J Diabetes Sci Technol 2013
13
23


Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.
Elizabeth Selvin, Michael W Steffes, Hong Zhu, Kunihiro Matsushita, Lynne Wagenknecht, James Pankow, Josef Coresh, Frederick L Brancati. N Engl J Med 2010
935
3

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
3

Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes.
Francesca Porcellati, Paola Lucidi, Geremia B Bolli, Carmine G Fanelli. Diabetes Care 2013
46
6

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.
Denise E Bonds, Michael E Miller, Richard M Bergenstal, John B Buse, Robert P Byington, Jeff A Cutler, R James Dudl, Faramarz Ismail-Beigi, Angela R Kimel, Byron Hoogwerf,[...]. BMJ 2010
607
3

The barrier of hypoglycemia in diabetes.
Philip E Cryer. Diabetes 2008
406
3

Three-year efficacy of complex insulin regimens in type 2 diabetes.
Rury R Holman, Andrew J Farmer, Melanie J Davies, Jonathan C Levy, Julie L Darbyshire, Joanne F Keenan, Sanjoy K Paul. N Engl J Med 2009
440
3

A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES).
Glen H Murata, Richard M Hoffman, Jayendra H Shah, Christopher S Wendel, William C Duckworth. Arch Intern Med 2004
50
6



Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
3

Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias.
Annett Stahn, Frank Pistrosch, Xenia Ganz, Madlen Teige, Carsta Koehler, Stefan Bornstein, Markolf Hanefeld. Diabetes Care 2014
94
3

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda, Ling Ge, Madeline McCarren, William C Duckworth, Nicholas V Emanuele. N Engl J Med 2015
353
3

Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.
Elaine Chow, Alan Bernjak, Scott Williams, Robert A Fawdry, Steve Hibbert, Jenny Freeman, Paul J Sheridan, Simon R Heller. Diabetes 2014
216
3

Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients.
Yifei Mo, Jian Zhou, Mei Li, Yuwei Wang, Yuqian Bao, Xiaojing Ma, Ding Li, Wei Lu, Cheng Hu, Minghua Li,[...]. Cardiovasc Diabetol 2013
29
10

Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose.
B P Kovatchev, D J Cox, L S Farhy, M Straume, L Gonder-Frederick, W L Clarke. J Clin Endocrinol Metab 2000
67
4

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.
Linda G Mellbin, Lars Rydén, Matthew C Riddle, Jeffrey Probstfield, Julio Rosenstock, Rafael Díaz, Salim Yusuf, Hertzel C Gerstein. Eur Heart J 2013
148
3

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT.
S E Siegelaar, E S Kilpatrick, A S Rigby, S L Atkin, J B L Hoekstra, J H Devries. Diabetologia 2009
48
6



Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes.
Alexia S Peña, Jennifer J Couper, Jennifer Harrington, Roger Gent, Jan Fairchild, Elaine Tham, Peter Baghurst. Diabetes Technol Ther 2012
34
8

Glycemic variability: both sides of the story.
Antonio Ceriello, Eric S Kilpatrick. Diabetes Care 2013
60
5



Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia.
Assam El-Osta, Daniella Brasacchio, Dachun Yao, Alessandro Pocai, Peter L Jones, Robert G Roeder, Mark E Cooper, Michael Brownlee. J Exp Med 2008
671
3




Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.
N H White, D A Skor, P E Cryer, L A Levandoski, D M Bier, J V Santiago. N Engl J Med 1983
379
3

Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysis.
Lalo Magni, Davide M Raimondo, Chiara Dalla Man, Marc Breton, Stephen Patek, Giuseppe De Nicolao, Claudio Cobelli, Boris P Kovatchev. J Diabetes Sci Technol 2008
65
4



Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
S A Amiel, R S Sherwin, D C Simonson, W V Tamborlane. Diabetes 1988
362
3

Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.
M Barbieri, M R Rizzo, R Marfella, V Boccardi, A Esposito, A Pansini, G Paolisso. Atherosclerosis 2013
102
3






Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.